ЛЕКТОРЫ

Ondrej Hes
MD, Ph.D.

Education

  • 1993 graduation M.D., general medicine, Faculty of Medicine in Pilsen, Charles University, CZ
  • 1996 Board Certificate in Pathology 1st degree
  • 1999 Board Certificate in Pathology 2nd degree (both certificate at Institute for Post Graduate Training of Physicians and Pharmacists in  Prague, CZ)
  • 2001 Graduation Ph.D., Faculty of Medicine in Pilsen, Charles University, CZ
  • 2003 Associated Professor of Pathology, Charles University, Prague, CZ
  • 2009 Professor of Pathology, Charles University, Prague, CZ
  • Founding member of Genitourinary Pathology Society

 

Present appointment

  • Head of Laboratory of Special Diagnostics, Department of Pathology, Charles University Hospital Pilsen, CZ

Medical Council Registration

  • Czech Medical Society of J. E. Purkyně, Czech Urological Society, Czech Pathological Society, International Academy of Pathology, Czech Gynecological Society, GUPS (Genitourinary Pathological Society)

Working Groups

  • 2011: Member of working group Classification of Renal Tumors, International Society of Urogenital Pathology (ISUP)
  • 2015: WHO-blue book: Kidney Tumours
  • 2015: ENUP (European Network of Urogenital Pathology)

Publications

  • More than 364 papers according Medline (November 2019)
  • More than 4700 citations according Web of Science (November 2019)
  • H index 33 (November 2019)

Editorial boards

  • Čs. Urologie, Pathologia- Revista Latinoamericana, Annals Diagnostic Pathology, Case Reports in Pathology, Vichows Archives, Histology Histopathology

Maria Tretiakova
MD, PhD, FCAP, Associate Professor

Founding member of Genitourinary Pathology Society. She is a board-certified anatomic and clinical pathologist at the University of Washington in Seattle, Director of Immunohistochemistry Laboratories, co-chief of service in the Pathology Department of a major tertiary Medical Center serving 5 states (Washington, Wyoming, Alaska, Montana and Idaho) that has unique expertise in diagnostics and treatments of complex medical urologic disorders. She is an Associate Professor at the University of Washington, School of Medicine, Director of Genitourinary Fellowship and Clerkship Programs, and a recipient of the Outstanding Anatomical and Clinical Pathology Teaching Award.

Dr Tretiakova is a leading expert in Kidney Cancer Multidisciplinary Clinic at the Seattle Cancer Care Alliance, Prostate Cancer SPORE program at Fred Hutchinson Cancer Research Center (Seattle) and Canary Foundation (Stanford). Dr Tretiakova is on Editorial Board of Human Pathology, PathologyOutlines, Journal of Oncology, Annals of Clinical Pathology; member of the College of American Pathologists (CAP), United States and Canadian Academy of Pathology (USCAP), American Society of Clinical Pathology (ASCP), Educational committee chair of the International Society of Urologic Pathology (ISUP), board member of the Genitourinary Pathology Society (GUPS), board member and chair of Educational committee of the Washington State Society of Pathologists (WSSP).

A summa cum laude graduate from the Saint Petersburg State Medical Academy (Russia), she completed her anatomic pathology training and received a doctor of philosophy (PhD) degree at the Saint Petersburg State Medical Academy (currently North-Western State Medical University named after I.I. Mechnikov). Dr. Tretiakova remained as faculty there before moving to the United States where she completed postgraduate training and directed Human Tissue Resource Center at the University of Chicago. She completed her clinical and anatomic pathology residency training at the University of Chicago combined with genitourinary pathology subspecialty training at John Hopkins University, Memorial Sloan Kettering and MD Anderson Cancer Centers establishing herself among leading experts in the field of urologic pathology.

In recognition of her lifelong academic dedication and professional excellence, she received grants from the European Society of Pathologists (ESP), National Cancer Institute and National Institute of Health (USA), awards from the American Society of Nephrology and ASCP, ISUP stipend, research awards from Russian Academy of Sciences and Russian Academy of Medical Sciences, Chicago Pathology Society and International Academy of Pathologists. Her passionate teaching was acknowledged by mentorship awards from the University of Washington, PathologyOutlines, ASCP and USCAP.

A prolific cancer researcher and translational scientist, Dr Tretiakova has published over 200 original articles, reviews, case reports and book chapters.

Dr. Ming Zhou

President elect of Genitourinary Pathology Society. He is the Pathologist-in-Chief and Chair of the Tufts Medical Center Department of Pathology, and the Chair of the Department of Anatomic and Clinical Pathology, Tufts University School of Medicine in Boston, MA. He was previously the Dr. Charles T Ashworth Endowed Professor of Pathology and the Director of Anatomic Pathology in the Department of Pathology, the University of Texas Southwestern Medical Center in Dallas. He graduated summa cum laude from Fudan University Medical School in Shanghai, China. He completed his pathology residency training at the University of Michigan and a fellowship in the Urological and Kidney Diseases at the Johns Hopkins Hospital. He was previously at Cleveland Clinic and New York University.

Dr. Zhou has devoted his clinical and research effort to diagnostic urological pathology, and discovery and validation of tumor markers for urological malignancy. He has authored over 200 peer-reviewed articles and numerous book chapters, and is the editor of 5 textbooks of urological and prostate pathology. He frequently lectures at national and international meetings on urological pathology. He was the co-course director of the prostate cancer long course at the 2018 USCAP annual meeting. He served on the Cancer Committee of the College of American Pathologists from 2011 to 2017 and is one of the primary authors of the genitourinary cancer protocols, the guidelines for practicing pathologists on diagnosis and reporting genitourinary cancers. He also serves on the editorial board of several pathology journals, including Modern Pathology and Pathology International.

Eva Comperat

1991 — Diploma of MD
1995 — Diploma of General Practitioner
2000 — Graduate of biological and medical science (Maîtrise de sciences biologiques et médicales, Université Paris VI)
2001 — Master of biological and medical science (Diplôme des Etudes Approfondies, Université Paris VI)
2002 — Diploma of Specialist of Pathology
2006 — PhD, Université Paris VII
2011 — HDR (habilitation à diriger des recherches), Université Paris VI
2017 — Full Professor
2016 — Head of the Dpt Pathology, Hôpital Tenon, AP-HP, UPMC Paris VI

 

Since 2003 specialised in uropathology
Since 2010 consulting pathologist in CCAFU (Comité de cancérologie de l’Association Française d’Urologie) for bladder cancer
Since 2011 consulting Pathologist of NMIBC (non muscle invasive bladder cancer) and MIBC (muscle invasive bladder cancer) for EAU Guidelines
Since 2013 consulting Pathologist in penile carcinoma for EAU Guidelines

Co-author of the guidelines in these specialties
Coauthor of the 4th Ed WHO Tumours of the Urinary System and Male genital organs (Coauthor 4 chapters, responsible of 3 chapters)
ISUP (International Society of Uro-Pathology) head of the working group 5 in the upcoming consensus of prostate cancer reporting
Voting member in the consensus conference 2014, (Grade groups, Gleason modified included into the WHO 2016, paper AJSP 2016)
Member of the consensus conference in testicular tumors (Boston 2015)
ICCR (International Collaboration on Cancer Reporting) active member in 6 of 12 chapters of uroinary/male genital database chapters  (www.cancer-org.com)
SIU (Societé Internationale d’Urologie) responsible for chapter „Pathology“ published in 2018 „Bladder Cancer»
Co-author in the upcoming ESMO guidelines on bladder cancer and penile carcinomas
Author of the pathology chapter in the upcoming AEU Spanish Guidelines
GUPS (Genito-urinary Pathology Society) member of the CA and responsible for the educational programm

Editorial board

  • 2013 World Journal of Urology
  • 2014 Pathology
  • 2018 European Urology Oncology
  • 2019 Actas Urológicas Españolas and PLoS
  • De 2005-2011 Editorial board et Section editor “Archives of Pathology and Laboratory”
  • De 2010-2014 Scandinavian Journal of Urology and Nephrology

Membership

  • ISUP (International Society of Uro Pathology)
  • GUPS (Genito Urinary Pathology Society)
  • ICCR (International Collaboration on Cancer Reporting)
  • SIU (Societé Internationale d’Urologie)
  • EAU (European Association of Urology)
  • AIP (Académie Internationale de Pathologie) Division Française
  • AFU (Association Française d’Urologie)
  • ESMO (European Society of Medical Oncology)
  • Author of several book chapters
  • Author/co-author of more than 330 peer reviewed papers indexed on “pubmed”
  • Teaching since 2002 at the Université Pierre et Marie Curie (UPMC), Paris VI
  • Teaching at the International Academy of Pathology (IAP) (urinary cytology, bladder and prostate cancer, flat lesions of the bladder, testicular tumours)

Dr. Magi-Galluzzi
MD, PhD

Professor of Pathology
Division Director of Anatomic Pathology
The C. Bruce Alexander Endowed Professorship in Pathology
Founding member of Genitourinary Pathology Society

Dr. Magi-Galluzzi is the Division Director of Anatomic Pathology and Professor of Pathology at the University of Alabama at Birmingham. She received her MD at the University of Ancona, School of Medicine, Italy and her PhD in Oncologic Human Pathology at the University of Verona, Italy. She has completed her residency in Anatomic and Clinical Pathology at Rush University Medical Center in Chicago (1997-1999) and Brigham & Women’s Hospital, Harvard Medical School in Boston (1999-2001), followed by a fellowship in Urologic Pathology at the Johns Hopkins University in Baltimore (2001-2003). She has been on staff at the Cleveland Clinic from 2003 to 2018 and Director of Genitourinary pathology from 2004 to 2018.

Her clinical expertise is the pathological diagnosis of genitourinary diseases, including prostate, bladder, testicular, adrenal and kidney malignancies. Her research interest focuses on prostate carcinogenesis and in the discovery and validation of tumor markers and genomic tests of value in furthering the goals of successful treatment and understanding of the pathogenesis of genitourinary disease. She is the author of numerous (~220) peer-reviewed publications, invited reviews and book chapters, as well as the editor of two books on genitourinary pathology. She has presented and lectured extensively at national and international meetings and has conducted national and international courses, workshops and slide seminars in urological pathology. She is a founding member of the Genitourinary Pathology Society (GUPS).

Currently, Dr. Magi-Galluzzi is a member of the USCAP Board of Directors and the secretary of the Arthur Purdy Stout Society (APSS).

Mahul B. Amin

Professor and Chairman
Department of Pathology and Laboratory Medicine
Founding member of Genitourinary Pathology Society
Gerwin Endowed Chair for Cancer Research
Professor of Urology
Director, Translational Research, UTHSC Cancer Research Center
University of Tennessee Health Sciences
Pathologist-in Chief, University Clinical Health
Chairman, Department of Pathology and Laboratory Medicine, Methodist Le Bonheur Health System
Editor-in-Chief, Advances in Anatomic Pathology

 

Dr. Mahul Amin is an internationally recognized researcher, leading urologic pathologist and highly effective operations executive, with consistent success heading up clinical practice and research transformations in translational research pathology, leading growth, and increasing industry recognition for large academic laboratories and university- based Pathology departments.  Dr Amin is the Professor and Chair of the Department of Pathology and Laboratory Medicine, Professor of Urology, Gerwin Endowed Chair for Cancer Research, and Associate Director of Translational Research for the Cancer Research Centre at University of Tennessee Health Sciences Centre (UTHSC). He conducts his clinical practice as the Chief of Pathology at Methodist Le Bonheur Health System and University Clinical Health, Memphis, TN.

Dr. Amin earned his medical degree at G.S. Medical College and King Edward Memorial Hospital in Bombay, India. From 2001 to 2009, as Vice Chair and then as Chair of the Cancer Committee of the College of American Pathologists (CAP), Dr. Amin led the cause for standardized pathologic reporting of all cancer in the United States and the committees’ work resulted in one of the important standards of the American College of Surgeons, Commission on Cancer center accreditation program in the United States and the CAP’s laboratory accreditation program. In 2013, he was appointed as Editor-in-Chief of the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual where he coordinated the activities of over 425 contributors (surgical oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, cancer registrars, clinical epidemiologists and members from the cancer surveillance, computational biology and bioinformatics community) from 184 institutions, 23 countries, 5 continents to outline the next edition of cancer staging (staging manual published in October 2016). The AJCC TNM staging system is widely used in clinical decision-making of all patients with cancer, to define clinical and translational research and healthcare policy in cancer. Dr Amin is also on the Editorial board of the 8th edition UICC TNM Classification of Malignant Tumors.  Due to his role in cancer staging, Dr. Amin serves as an observer to the editorial board of the WHO Blue book series.

Dr. Amin’s scientific interests are in the discovery and validation of biomarkers in urologic malignancies for clinical personalized medicine and in Artificial Intelligence applications in Pathology. He has authored 364 publications and 73 book chapters. Dr. Amin’s H Index is 107 and his i10 index is 368; his work has 67,099 citations (data from Google Scholar January 4, 2020) [among 36 new inductees in the National Academy of Sciences in biological and biomedical sciences in 2005, the median h-index was 57].  He has also co-authored 13 books (two in their second and third editions) including two Armed Forces Institute of Pathology (AFIP) fascicles, two major texts in urologic pathology and a monograph on Gleason grading of prostate cancer. Dr. Amin is a much sought of as a speaker and has given 380 pathology grand rounds, lectures and workshops. He has extensively spoken around the world and lectured in 31 countries and 75 cities outside of the US; often on multiple occasions.  Dr. Amin is a co-author of the Urinary tract chapter in the world’s most widely sold medical textbook – Robbins’ Pathological Basis of Disease (10th edition – In Press). He has been a member of the national faculty for courses for the American Urology Association (AUA since 1990), United States and Canadian Academy of Pathologists (USCAP) (since 1995), American Society for Clinical Pathologists (since 1994), College of American Pathologists (since 2003) and recently American Society of Clinical Oncology (ASCO). Dr. Amin has been training fellows in Urologic Pathology since 1997 and has trained over 20 fellows many of whom are now expert uropathologists and on faculty at prestigious institutions like M.D. Anderson and Memorial Sloan Kettering Cancer Centers, Mayo Clinic, Cleveland Clinic, University of Chicago, University of Southern California etc. Trained pathologists from over 12 countries have spent time visiting and signing out cases with him.

Dr. Amin is a national and international consultant in tumors of the genitourinary tract, including prostate, urinary bladder, kidney, and testis.  Dr. Amin is a world-renowned expert and educator in genitourinary pathology having co-authored the 2002 World Health Organization (WHO) classification systems for urothelial tumors and renal neoplasms (authored 7 chapters); and the 2016 WHO classification systems for tumors of the prostate, bladder, kidney, penis and testis (authored 21 chapters). He has made many significant and pioneering contributions including the first major descriptions of entities in genitourinary pathology including lymphoepithelioma-like carcinoma of the bladder, micropapillary carcinoma of the bladder, acquired cystic disease associated renal cell carcinoma, clear cell-papillary renal cell carcinoma, thyroid-like carcinoma of the kidney, tubulocystic carcinoma of the kidney, intratubular large cell hyalinizing sertoli cell neoplasia of the testis (a distinctive condition of the Peutz-Jeghers syndrome), and low-grade glandular tumors of the urachus. He has recently authored some of the first major series and descriptions on Succinate dehydrogenase — deficient renal cell carcinoma and Fumarate hydratase- deficient renal cell carcinoma, including decription of a new subtype of renal cell carcinoma — low grade oncoctytic Fumarate Hydratase deficient renal cell carcinoma. Dr. Amin was the co-first author on the new Prostate Cancer Foundation sponsored proposed classification for neuroendocrine tumors of the prostate. Dr. Amin was involved in developing the 7th (2010) edition and 8th (2017) edition of the AJCC TNM staging of prostate cancer; he was a co-organizer and co-author of the influential International Society of Urologic Pathologists Consensus Conference papers on Gleason Grading of Prostate cancer (2004 and 2014 meetings). Thus, Dr. Amin has for over two decades helped set the standards of grading and staging of prostate cancer, which are vital for appropriate management of prostate cancer patients around the world. Dr. Amin has helped bring several diagnostic markers (based on first major publications and widespread implementation) in clinical practice including CK20, p53 and CD44 in the diagnosis of flat lesions of the bladder, smoothelin in the recognition of muscularis propria of the bladder, S100p and uroplakin 2 and 3 in confirming bladder histogenesis, and kidney specific cadherin and cathepsin K in renal tumor classification.His recent interests are in Artificial Intelligence and its applications to Urologic Pathology and Anatomic Pathology work flows.  Dr. Amin serves on the Executive Committee of the AJCC (2003-2011; 2013-2017), and was a member of the Genitourinary Cancer Staging Task Force, 7th Edition of AJCC staging, and lead coordinator of the prostate cancer staging system.  Dr. Amin was the North American Representative to the International Society of Urologic Pathologists (ISUP) from 2012-2015 and has served on numerous committees and roles in the United States and Canadian Academy of Pathology including the finance committee. He has a been a Director of Urologic Pathology fellowships since 1997 and his trainees practice, teach and/or conduct research in departments all over the world. Dr. Amin is the Editor-in-Chief of Advances in Anatomic Pathology since the year 2000, and serves on the editorial boards of numerous prestigious medical journals.